RPH3AL and neoplasm: The only known gene in the precise region chr17:118,535–134,424 is RPH3AL, but there exists no conclusive evidence for a tumor suppressive role [47], [48] despite the fact that loss of 17p13.3 is strongly associated with poor recurrence-free and disease-specific survival.